Development of slow release reagent of NFkB decoy oligodeoxynucleotides for the treatment of rheumatic arthritis
Development of slow release reagent of NFkB decoy oligodeoxynucleotides for the treatment of rheumatic arthritis
批准号:
13558109
负责人:
KANEDA Yasufumi
金额:
$8.13万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
我们试图在不降解的情况下延长NFkB寡脱氧核苷酸的释放。首先,我们测试了使用间胶原蛋白将fitc标记的寡核苷酸导入培养细胞的效率。转染HeLa、BHK-21和人舌癌细胞SAS 48h后,未见荧光。在此基础上,构建了日本血凝病毒(HVJ,仙台病毒)包膜载体,该包膜载体可以引入合成的寡核苷酸、蛋白质、多肽和化学药物以及基因。将fitc标记的寡核苷酸通过温和洗涤剂处理和离心将其纳入HVJ包膜载体中。将上述培养细胞与HVJ包膜载体孵育10分钟后,几乎所有细胞核均可见荧光。利用HVJ包膜载体将NFkB诱骗寡核苷酸导入SAS、HeLa等肿瘤细胞,通过抑制NFkB诱导的…More基因的表达,增强了辐照后的细胞凋亡。利用HVJ包膜载体将fitc标记的NFkB诱骗寡核苷酸引入食蟹猴关节间隙,在滑膜和关节软骨处均检测到荧光。然后,在HVJ包络向量上嵌入各种聚合物。首先,不加聚合物,HVJ包膜载体经静脉注射到达脾脏,在小鼠脾脏边缘区检测fitc寡核苷酸。然后,将含有荧光素酶基因的载体用硫酸鱼精蛋白修饰,并将复合物注入小鼠尾静脉。基因表达仅在肺中检测到,在脾脏中未检测到。此外,当混合肝素的HVJ包膜载体直接注射到肌肉或大脑时,基因表达量比不加肝素的增加了约5倍。目前正在研究聚合物对HVJ包膜载体缓释的影响,但我们已经得到了初步的数据表明阳离子聚合物可能会促进HVJ包膜载体的缓释。少
英文摘要
We attempted to prolong release of NFkB oligodeoxynudeotid.es without degradation. First, we tested the efficiency of introduction of FITC-labeled oligonucleotides into cultured cells using atelocollagen. No fluorescence was detected at 48 hours after the transfer to HeLa, BHK-21 and human tongue cancer cell line SAS. Then, we developed HVJ (hemagglutinating virus of Japan ; Sendai virus) envelope vector which can introduce synthetic oligonucleotides, proteins, peptides and chemical drugs as well as genes. FITC-labeled oligonucleotides were incorporated into HVJ envelope vector by the treatment of mild detergent and centrifugation. Ten minutes after incubation of those cultured cells described above with the HVJ envelope vector, fluorescence was observed in almost all the nuclei of the cells. When NFkB decoy oligonucleotides were introduced into cancer cells such as SAS and HeLa cells using HVJ envelope vector, apoptosis after irradiation was enhanced by the suppression of NFkB-induced … More gene expression. When FITC-labeled NFkB decoy oligonucleotides were introduced into the joint space of Cynomolgus monkeys using HVJ envelope vector, fluorescence was detected at both synovium and articular cartilage. Next, HVJ envelope vector was embedded with various polymers. First, without polymer, HVJ envelope vector reaches spleen by intravenous injection and FITC-oligonucleotides were detected at the marginal zone of mouse spleen. Then, the vector containing luciferase gene was decorated with protamine suifate and the complex was injected into tail vein of mouse. Gene expression was detected exclusively in lung, not in spleen. Furthermore, when HVJ envelope vector mixed with heparin was injected into muscle or brain directly, gene expression was approximately 5 fold increased than that without heparin. The effect of polymers on slow release of the vector is being investigated, but we have got preliminary data suggesting that cationic polymers may enhance slow release of HVJ envelope vector. Less
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kaneda, Y.: "Pharmaceutical Gene Delivery Systems"Alain Rolland and Sean Sullivan(in press). (2003)
Kaneda, Y.:“药物基因传递系统”Alain Rolland 和 Sean Sullivan(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Taniyama, Y., Tachibana, K., Hiraoka, K., Nainba, T., Yamasaki, K., Hashiya, N., Aoki, M., Ogihara, T., Kaneda, Y., and Morishita, R.: "Local delivery of plasmid DNA into rat carotid artery using ultrasound"Circulation. 105. 1233-1239 (2002)
Taniyama, Y.、Tachibana, K.、Hiraoka, K.、Nainba, T.、Yamasaki, K.、Hashiya, N.、Aoki, M.、Ogihara, T.、Kaneda, Y. 和 Morishita, R.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Endoh, M., Koibuchi, N., Sato, M., Morishita, R., Kanzaki, T., Murata, Y. and Kaneda, Y: "Fetal gene transfer by intra-uterine injection with microbubble-enhanced ultrasound"Molecular Therapy. 5. 501-505 (2002)
Endoh, M.、Koibuchi, N.、Sato, M.、Morishita, R.、Kanzaki, T.、Murata, Y. 和 Kaneda, Y:“通过微泡增强超声子宫内注射进行胎儿基因转移”分子
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kaneda, Y., Nakajima, T., Nishikawa, T., Yamamoto, S., Ikegami, H., Suzuki, N., Nakamura, H., Morishita, R, and Kotani, H: "HVJ (hemagglutinating virus of Japan) envelope vector as a versatile gene delivery system"Molecular Therapy. 6. 219-226 (2002)
Kaneda, Y.、Nakajima, T.、Nishikawa, T.、Yamamoto, S.、Ikegami, H.、Suzuki, N.、Nakamura, H.、Morishita, R 和 Kotani, H:“HVJ(血凝病毒
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ueno, T., et al., Kaneda, Y., Matsuda, H.: "Nuclear factor-kB decoy attenuates neuronal damage after global brain ischemia ; a future strategy for brain protection during circulatory arrest"Cardiopulomonary Support and Physiology. 122. 720-727 (2001)
Ueno, T., et al., Kaneda, Y., Matsuda, H.:“核因子-kB 诱饵可减轻全脑缺血后的神经元损伤;循环停止期间脑保护的未来策略”心肺支持和生理学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
Molecular mechanism of cancer cell pluripotency responding to stress
-
批准号:24659149
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:KANEDA Yasufumi
-
依托单位:
Development of multi-lateral cancer gene therapy by enhancing anti-tumor activity of inactivated Sendai virus particle
-
批准号:22300339
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2010
-
负责人:KANEDA Yasufumi
-
依托单位:
Transcriptional regulation of osteogenesis using siRNA and its application to bone formation
-
批准号:17300153
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.55万
-
财政年份:2005
-
负责人:KANEDA Yasufumi
-
依托单位:
Development of anti-cancer strategy to increase sensitivity of cancer cells to chemotherapy using siRNA combined with HVJ-E vector
-
批准号:15300163
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.51万
-
财政年份:2003
-
负责人:KANEDA Yasufumi
-
依托单位:
Basic study of correction of mutated gene in xeroderma pigmentosum group A
-
批准号:10470505
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.26万
-
财政年份:1998
-
负责人:KANEDA Yasufumi
-
依托单位:
Isolation and characterization of tumor-specific antigen toward cancer gene therapy
-
批准号:09044306
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:KANEDA Yasufumi
-
依托单位:
Development of new DDS to individual organs by means of cell technology and its opplication to treatment of human diseases
-
批准号:07558126
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$6.21万
-
财政年份:1995
-
负责人:KANEDA Yasufumi
-
依托单位:
Joint Study on the Therapy of Diseases by Gene Transfer
-
批准号:05044170
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$5.44万
-
财政年份:1993
-
负责人:KANEDA Yasufumi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
苏木酮A介导NLRX1调控TRAF6/NF-κB抑制破骨细胞分化缓解骨质疏松症的机制研究
-
批准号:2026JJ82705
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘中
-
依托单位:
贝母素乙通过激活NF-κB信号通路调控线粒体功能障碍介导三阴型乳腺癌细胞焦亡的作用机制研究
-
批准号:2026JJ80203
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:易念
-
依托单位:
嗜黏蛋白阿克曼菌通过AMPK/SIRT1/NF-κB信号通路调节非酒精性脂肪肝的机制研究
-
批准号:2026JJ80624
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李昌敏
-
依托单位:
丁酸梭菌分泌的丁酸通过TLR4/NF-κB信号通路调控ICCs介导ICH后胃肠动力的机制研究
-
批准号:2026JJ80329
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘艳辉
-
依托单位:
片仔癀通过调控TLR4/NF-κB/Nrf2通路减轻大面积烧伤后肠道屏障损伤的机制研究
-
批准号:2026JJ80347
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李波
-
依托单位:
草鱼NF-κB p50与IL-10启动子的结合特性及其调控效应
-
批准号:2026JJ60378
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:阳鸿
-
依托单位:
基于“阳和通腠”理论探讨阳和逐瘀汤通过内质网应激介导IRE1α-TRAF2-NF-κB抗骨转移癌痛的作用机制
-
批准号:2026JJ82466
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:孙铜林
-
依托单位:
干葛散调控TLR4/MyD88/NF-κB轴改善HaCat细胞炎症反应治疗特应性皮炎作用机制研究
-
批准号:2026JJ81892
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张小娟
-
依托单位:
基于TLR4/P38MAPK/NF-ΚB通路的栀子苷和大黄素配伍抗脓毒症肠屏障炎性损伤研究
-
批准号:2026JJ81968
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邓怒骄
-
依托单位:
辣椒平调控NF-κB/NLRP3 炎症小体通路在快速进展型尘肺中的作用
-
批准号:2026JJ81460
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈柔
-
依托单位: